Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.
about
Interventions for preventing critical illness polyneuropathy and critical illness myopathyProlonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired WeaknessClinical review: intensive care unit acquired weaknessYear in review 2010: Critical Care--Neurocritical careInflammation-induced acute phase response in skeletal muscle and critical illness myopathyEarly changes of muscle membrane properties in porcine faecal peritonitis.Electrophysiology of neuromuscular disorders in critical illness.Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study.Screening for critical illness polyneuromyopathy with single nerve conduction studies.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy.Associations between muscle-related cytokines and selected patient outcomes in the ICUIntensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockA conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome.Functional evolution of critically ill patients undergoing an early rehabilitation protocol.Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy?Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical IllnessYear in review 2011: Critical Care--Neurocritical care.ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children.Persistent systemic inflammation in chronic critical illness.Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms.Clinical review: Acute respiratory distress syndrome - clinical ventilator management and adjunct therapy.Exercise limitation following transplantation.Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults.The role of inflammation in ICU-acquired weaknessSedation and neuromuscular blocking agents in acute respiratory distress syndrome.Mechano-signalling pathways in an experimental intensive critical illness myopathy model.Critical illness myopathy in a cervical spine-injured patientDeletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophyDynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.Critical illness myopathy and GLUT4: significance of insulin and muscle contraction.[Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].Muscle membrane properties in A pig sepsis model: Effect of norepinephrine.Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie
P2860
Q24200934-FC73E5A6-BD83-4ACB-9BA4-232A758CE8A0Q26741099-9865786B-9C32-45C3-84AC-711F3DCEBD0CQ26799076-55516209-EDA7-4EC1-8F29-3AEC37CAAD7BQ27016627-EE4901C4-8662-4C77-BE03-9E047AE9C276Q27314918-6ABEACE0-725F-4467-80D3-D122A0411E15Q34157055-7A8A01E9-26F4-47AF-B870-943EA7F77D60Q34326509-B411F042-E112-47C6-9358-D554497305E3Q34408307-573A174A-5F4C-456E-B2A5-E2AC72DA4919Q34409781-0924B7D6-8083-4971-8825-21983590E9DBQ34483183-7F96A5DC-39C3-49BF-975A-8551EC30F652Q34507052-89CFAE21-5550-4E86-90A6-80FC8D9775BCQ34587760-0D31EF14-41C8-4FC0-96C6-956F1C673D37Q34697264-B4E4667F-0D0C-40A9-850A-8EBBDF695F2EQ35809472-CD3D7234-D823-4333-BDB2-A9C0003C014CQ35811384-46414CF9-73DF-4B26-9986-33489A1D38E4Q35908283-8E63D05D-62DB-4C7E-AAA7-1E693F29D0A3Q36296818-EDCFE7E3-7956-4F48-8176-A5356284B8CAQ36902672-92B3987F-9949-46C9-9109-20C2F5390904Q37227130-D51A6378-E434-4AF1-B72E-F95E104D61BBQ38015927-102724BB-C9CC-4375-B06C-E8ABB7E7C338Q38064396-1FE9030F-06A0-4A5F-890D-160730D17F4DQ38106772-BFC57CDA-F382-4E7C-BFBC-D9ED5AB499C7Q38110753-0CDA5FA3-1011-40FB-8182-55B7664E4E3DQ39490900-529C3016-8B27-43DA-B95C-6BCCED626971Q39845538-8D6A4634-7F2E-4ACF-B4E3-F5DF8F6425E3Q40084781-8EB80E9E-BEE2-4C69-9DDD-812B21F36C29Q40846168-54DDEE56-AEB4-4C3A-8ABD-BABFF38E0719Q41815188-F48F0845-2438-4C1B-ACE0-A4A729F9F590Q42330082-A4DC4BE8-5DFD-4A66-924B-F39F955071D2Q42643598-EB6307E7-57E6-44ED-A2D5-EA13444F94C6Q43483723-28238D43-5EF1-458B-9E45-C23BCD0DC794Q44967218-67F7035C-42D6-40EE-B046-6E27569C3AFAQ50052360-9047BD1F-CAF6-4692-96F8-F1FDB5EEBF8BQ57727089-550DD2A0-AEBD-4C8B-9E45-892BD21C7F51
P2860
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk factors in critical illne ...... ospective observational study.
@ast
Risk factors in critical illne ...... ospective observational study.
@en
Risk factors in critical illne ...... ospective observational study.
@nl
type
label
Risk factors in critical illne ...... ospective observational study.
@ast
Risk factors in critical illne ...... ospective observational study.
@en
Risk factors in critical illne ...... ospective observational study.
@nl
prefLabel
Risk factors in critical illne ...... ospective observational study.
@ast
Risk factors in critical illne ...... ospective observational study.
@en
Risk factors in critical illne ...... ospective observational study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Risk factors in critical illne ...... ospective observational study.
@en
P2093
Didier Keh
Florian Bubser
Maria Deja
Simone Spuler
P2860
P2888
P356
10.1186/CC9074
P577
2010-06-18T00:00:00Z
P5875
P6179
1040341266